Novel Therapeutic Strategy for Triple Negative Breast Cancer Targeting hERO1-Lα

被引：0
|
作者：
Wada, Asaka [1 ,2 ]
Hirohashi, Yoshihiko [1 ]
Kutomi, Goro [2 ]
Shima, Hiroaki
Murata, Kenji [3 ,4 ]
Kubo, Terufumi [1 ]
Tsukahara, Tomohide [3 ,5 ]
Tamura, Yasuaki [1 ,6 ]
Torigoe, Toshihiko
Takemasa, Ichiro [2 ]
机构：
[1] Sapporo Med Univ, Dept Pathol, Sch Med, Sapporo, Japan
[2] Sapporo Med Univ, Dept Surg, Surg Oncol & Sci, Sapporo, Japan
[3] Sapporo Med Univ, Dept Path, Sapporo, Japan
[4] Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Sapporo Med Univ, Dept Orthop Surg, Sapporo, Japan
[6] Hokkaido Univ, Dept Mol Therapeut, Sapporo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2352
引用
收藏
页码：1486 / 1486
页数：1
相关论文
共 50 条
  • [1] A novel therapeutic strategy for triple-negative breast cancer targeting hERO1-Lα
    Wada, Asaka
    Kutomi, Goro
    Hirohashi, Yoshihiko
    Shima, Hiroaki
    Satomi, Fukino
    Kuga, Yoko
    Torigoe, Toshihiko
    Takemasa, Ichiro
    CANCER SCIENCE, 2022, 113 : 1051 - 1051
  • [2] Novel therapeutic strategy for breast cancer targeting hERO1-Lα, a regulator of EMT via LIF secretion
    Wada, Asaka
    Hirohashi, Yoshihiko
    Kutomi, Goro
    Shima, Hiroaki
    Tsukahara, Tomohide
    Kanaseki, Takayuki
    Kubo, Terufumi
    Murata, Kenji
    Takemasa, Ichiro
    Torigoe, Toshihiko
    CANCER SCIENCE, 2024, 115 : 2041 - 2041
  • [3] Targeting tankyrases as a therapeutic strategy for triple-negative breast cancer
    Mathew, Maya
    Campo, Loredana
    Kim, Jung-Lye
    Ha, Geun-Hyoung
    Breuer, Eun-Kyoung
    CANCER RESEARCH, 2017, 77
  • [4] A novel mechanism for therapeutic targeting of the glucocorticoid receptor in triple negative breast cancer
    Khan, Shagufta H.
    Carbe, Christian
    Ling, Jun
    Kumar, Raj
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Therapeutic targeting of ERβ in triple negative breast cancer
    Reese, Jordan M.
    Subramaniam, Malayannan
    Suman, Vera J.
    Wu, Xianglin
    Negron, Vivian
    Gingery, Anne
    Pitel, Kevin S.
    Shah, Sejal S.
    Cunliffe, Heather E.
    McCullough, Ann E.
    Pockaj, Barbara A.
    Spelsberg, Thomas C.
    Goetz, Matthew P.
    Ingle, James N.
    Hawse, John R.
    CANCER RESEARCH, 2015, 75
  • [6] EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
    Chao-Qun Wang
    Yang Li
    Bi-Fei Huang
    Yong-Ming Zhao
    Hui Yuan
    Dongfang Guo
    Chen-Ming Su
    Gui-Nv Hu
    Qian Wang
    Tengyun Long
    Yan Wang
    Chih-Hsin Tang
    Xiaoni Li
    Scientific Reports, 7
  • [7] EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
    Wang, Chao-Qun
    Li, Yang
    Huang, Bi-Fei
    Zhao, Yong-Ming
    Yuan, Hui
    Guo, Dongfang
    Su, Chen-Ming
    Hu, Gui-Nv
    Wang, Qian
    Long, Tengyun
    Wang, Yan
    Tang, Chih-Hsin
    Li, Xiaoni
    SCIENTIFIC REPORTS, 2017, 7
  • [8] Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
    Xu, Jiangsheng
    Liu, Yunhua
    Li, Yujing
    Wang, Hai
    Stewart, Samantha
    Van der Jeught, Kevin
    Agarwal, Pranay
    Zhang, Yuntian
    Liu, Sheng
    Zhao, Gang
    Wan, Jun
    Lu, Xiongbin
    He, Xiaoming
    NATURE NANOTECHNOLOGY, 2019, 14 (04) : 388 - +
  • [9] Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
    Jiangsheng Xu
    Yunhua Liu
    Yujing Li
    Hai Wang
    Samantha Stewart
    Kevin Van der Jeught
    Pranay Agarwal
    Yuntian Zhang
    Sheng Liu
    Gang Zhao
    Jun Wan
    Xiongbin Lu
    Xiaoming He
    Nature Nanotechnology, 2019, 14 : 388 - 397
  • [10] A novel therapeutic approach for triple negative breast cancer
    Boopalan, Thiyagarajan
    Arumugam, Arunkumar
    Suman, Suman
    Das, Trinath P.
    Damodaran, Chendil
    Lakshmanaswamy, Rajkumar
    CANCER RESEARCH, 2012, 72
12345